The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey

If cytotoxin-associated gene A (CagA) status affects the response rates of therapy, then it may be possible to predict Helicobacter pylori eradication rates. We aimed to evaluate the response to eradication treatment of H. pylori infection in CagA-positive and CagA-negative patients. A total of 184 patients (93 males, 91 females, mean age 42.6 ± 12.8 years) with H. pylori-positive chronic gastritis were studied. Subjects underwent a gastroscopy and biopsy specimens were taken from the gastric antrum, body, and fundus. Before the eradication therapy was given all patients were tested for CagA, TNF-alpha and gastrin levels. They were then prescribed lansoprazole (30 mg bid), clarithromycin (500 mg bid), and amoxicillin (1.0 mg bid) for one week. On the 8th week a second endoscopy was performed and further biopsy specimens were obtained from the same sites as in the initial endoscopy. One hundred and twenty-seven patients (69.1%) were found to be CagA positive and 57 patients (30.9%) were CagA negative. The total eradication rate was 82.6%. In the CagA-positive group this rate was 87.4%, and in the CagA-negative group it was 71.9% (P = 0.019). TNF-alpha levels were higher in the CagA-positive than in the CagA-negative group (P = 0.001). However, gastrin levels were not different between groups (P = 0.421). Our findings revealed that CagA-negative status might be a risk factor for failure of H. pylori triple therapies. The CagA pathogenicity island gives a growth advantage to H. pylori strains and has been associated with an increase in the inflammatory response at the gastric mucosal level. These properties could make CagA-positive H. pylori strains more susceptible to antibiotics.

Saved in:
Bibliographic Details
Main Authors: Saruç,M., Goksel,G., Ozkaya,S., Guclu,F., Ozbakkaloglu,B., Yuceyar,H.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2001
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001001100010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2001001100010
record_format ojs
spelling oai:scielo:S0100-879X20010011000102001-11-07The effect of CagA status on response to Helicobacter pylori eradication therapy in Western TurkeySaruç,M.Goksel,G.Ozkaya,S.Guclu,F.Ozbakkaloglu,B.Yuceyar,H. Helicobacter pylori eradication cytotoxin-associated gene A CagA If cytotoxin-associated gene A (CagA) status affects the response rates of therapy, then it may be possible to predict Helicobacter pylori eradication rates. We aimed to evaluate the response to eradication treatment of H. pylori infection in CagA-positive and CagA-negative patients. A total of 184 patients (93 males, 91 females, mean age 42.6 ± 12.8 years) with H. pylori-positive chronic gastritis were studied. Subjects underwent a gastroscopy and biopsy specimens were taken from the gastric antrum, body, and fundus. Before the eradication therapy was given all patients were tested for CagA, TNF-alpha and gastrin levels. They were then prescribed lansoprazole (30 mg bid), clarithromycin (500 mg bid), and amoxicillin (1.0 mg bid) for one week. On the 8th week a second endoscopy was performed and further biopsy specimens were obtained from the same sites as in the initial endoscopy. One hundred and twenty-seven patients (69.1%) were found to be CagA positive and 57 patients (30.9%) were CagA negative. The total eradication rate was 82.6%. In the CagA-positive group this rate was 87.4%, and in the CagA-negative group it was 71.9% (P = 0.019). TNF-alpha levels were higher in the CagA-positive than in the CagA-negative group (P = 0.001). However, gastrin levels were not different between groups (P = 0.421). Our findings revealed that CagA-negative status might be a risk factor for failure of H. pylori triple therapies. The CagA pathogenicity island gives a growth advantage to H. pylori strains and has been associated with an increase in the inflammatory response at the gastric mucosal level. These properties could make CagA-positive H. pylori strains more susceptible to antibiotics.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.34 n.11 20012001-11-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001001100010en10.1590/S0100-879X2001001100010
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Saruç,M.
Goksel,G.
Ozkaya,S.
Guclu,F.
Ozbakkaloglu,B.
Yuceyar,H.
spellingShingle Saruç,M.
Goksel,G.
Ozkaya,S.
Guclu,F.
Ozbakkaloglu,B.
Yuceyar,H.
The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey
author_facet Saruç,M.
Goksel,G.
Ozkaya,S.
Guclu,F.
Ozbakkaloglu,B.
Yuceyar,H.
author_sort Saruç,M.
title The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey
title_short The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey
title_full The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey
title_fullStr The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey
title_full_unstemmed The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey
title_sort effect of caga status on response to helicobacter pylori eradication therapy in western turkey
description If cytotoxin-associated gene A (CagA) status affects the response rates of therapy, then it may be possible to predict Helicobacter pylori eradication rates. We aimed to evaluate the response to eradication treatment of H. pylori infection in CagA-positive and CagA-negative patients. A total of 184 patients (93 males, 91 females, mean age 42.6 ± 12.8 years) with H. pylori-positive chronic gastritis were studied. Subjects underwent a gastroscopy and biopsy specimens were taken from the gastric antrum, body, and fundus. Before the eradication therapy was given all patients were tested for CagA, TNF-alpha and gastrin levels. They were then prescribed lansoprazole (30 mg bid), clarithromycin (500 mg bid), and amoxicillin (1.0 mg bid) for one week. On the 8th week a second endoscopy was performed and further biopsy specimens were obtained from the same sites as in the initial endoscopy. One hundred and twenty-seven patients (69.1%) were found to be CagA positive and 57 patients (30.9%) were CagA negative. The total eradication rate was 82.6%. In the CagA-positive group this rate was 87.4%, and in the CagA-negative group it was 71.9% (P = 0.019). TNF-alpha levels were higher in the CagA-positive than in the CagA-negative group (P = 0.001). However, gastrin levels were not different between groups (P = 0.421). Our findings revealed that CagA-negative status might be a risk factor for failure of H. pylori triple therapies. The CagA pathogenicity island gives a growth advantage to H. pylori strains and has been associated with an increase in the inflammatory response at the gastric mucosal level. These properties could make CagA-positive H. pylori strains more susceptible to antibiotics.
publisher Associação Brasileira de Divulgação Científica
publishDate 2001
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001001100010
work_keys_str_mv AT sarucm theeffectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT gokselg theeffectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT ozkayas theeffectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT gucluf theeffectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT ozbakkaloglub theeffectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT yuceyarh theeffectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT sarucm effectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT gokselg effectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT ozkayas effectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT gucluf effectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT ozbakkaloglub effectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
AT yuceyarh effectofcagastatusonresponsetohelicobacterpylorieradicationtherapyinwesternturkey
_version_ 1756391007627247616